141 related articles for article (PubMed ID: 10876999)
1. Chlorzoxazone: a probe drug whose metabolism can be used to monitor toluene exposure in rats.
Mizuno D; Tanaka E; Tanno K; Misawa S
Arch Toxicol; 2000 May; 74(3):139-44. PubMed ID: 10876999
[TBL] [Abstract][Full Text] [Related]
2. Chlorzoxazone: a probe drug the metabolism of which can be used to monitor one-point blood sampling in the carbon tetrachloride-intoxicated rat.
Tanaka E
Hum Exp Toxicol; 2001 Aug; 20(8):381-5. PubMed ID: 11727787
[TBL] [Abstract][Full Text] [Related]
3. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
Mehvar R; Vuppugalla R
J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of chlorzoxazone in rats with diabetes: Induction of CYP2E1 on 6-hydroxychlorzoxazone formation.
Baek HW; Bae SK; Lee MG; Sohn YT
J Pharm Sci; 2006 Nov; 95(11):2452-62. PubMed ID: 16886191
[TBL] [Abstract][Full Text] [Related]
5. Chlorzoxazone metabolism by winter flounder liver microsomes: evidence for existence of a CYP2E1-like isoform in teleosts.
Wall KL; Crivello J
Toxicol Appl Pharmacol; 1998 Jul; 151(1):98-104. PubMed ID: 9705891
[TBL] [Abstract][Full Text] [Related]
6. Effects of normothermic hepatic ischemia-reperfusion injury on the in vivo, isolated perfused liver, and microsomal disposition of chlorzoxazone, a cytochrome P450 2E1 probe, in rats.
Shaik IH; Mehvar R
J Pharm Sci; 2011 Dec; 100(12):5281-92. PubMed ID: 21780121
[TBL] [Abstract][Full Text] [Related]
7. Effects of cytochrome P450 2E1 modulators on the pharmacokinetics of chlorzoxazone and 6-hydroxychlorzoxazone in rats.
Chen L; Yang CS
Life Sci; 1996; 58(18):1575-85. PubMed ID: 8649187
[TBL] [Abstract][Full Text] [Related]
8. Time-dependent effects of Klebsiella pneumoniae endotoxin on the pharmacokinetics of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, in rats: restoration of the parameters in 96 hour in KPLPS rats to control levels.
Jung HY; Kang HE; Choi YH; Kim SH; Lee MG
Biopharm Drug Dispos; 2009 Nov; 30(8):485-93. PubMed ID: 19753555
[TBL] [Abstract][Full Text] [Related]
9. Effect of 1-aminobenzotriazole on the in vitro metabolism and single-dose pharmacokinetics of chlorzoxazone, a selective CYP2E1 substrate in Wistar rats.
Muzeeb S; Pasha MK; Basha SJ; Mullangi R; Srinivas NR
Xenobiotica; 2005 Aug; 35(8):825-38. PubMed ID: 16278194
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a cytochrome P450 2E1 probe, chlorzoxazone, and its 6-hydroxy metabolite in poloxamer 407-induced hyperlipidemic rats.
Kwon MH; Lee CJ; Cho YY; Kang HE
J Pharm Pharm Sci; 2013; 16(4):648-56. PubMed ID: 24210069
[TBL] [Abstract][Full Text] [Related]
12. Impaired 6-hydroxychlorzoxazone elimination in patients with kidney disease: Implication for cytochrome P450 2E1 pharmacogenetic studies.
Nolin TD; Gastonguay MR; Bies RR; Matzke GR; Frye RF
Clin Pharmacol Ther; 2003 Dec; 74(6):555-68. PubMed ID: 14663458
[TBL] [Abstract][Full Text] [Related]
13. [Changes of CYP2E1 activity in diabetic rat model].
Li L; Zhang Y
Yao Xue Xue Bao; 1998 Dec; 33(12):891-5. PubMed ID: 12016852
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species.
Court MH; Von Moltke LL; Shader RI; Greenblatt DJ
Biopharm Drug Dispos; 1997 Apr; 18(3):213-26. PubMed ID: 9113344
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic parameters of chlorzoxazone and its main metabolite, 6-hydroxychlorzoxazone, after intravenous and oral administration of chlorzoxazone to liver cirrhotic rats with diabetes mellitus.
Ahn CY; Bae SK; Jung YS; Lee I; Kim YC; Lee MG; Shin WG
Drug Metab Dispos; 2008 Jul; 36(7):1233-41. PubMed ID: 18378564
[TBL] [Abstract][Full Text] [Related]
16. The effects of alcohol and diallyl sulphide on CYP2E1 activity in humans: a phenotyping study using chlorzoxazone.
Loizou GD; Cocker J
Hum Exp Toxicol; 2001 Jul; 20(7):321-7. PubMed ID: 11530830
[TBL] [Abstract][Full Text] [Related]
17. Effects of glucose supplementation on the pharmacokinetics of intravenous chlorzoxazone in rats with water deprivation for 72 h.
Kim YC; Lee I; Kim SG; Ko SH; Lee MG; Kim SH
Life Sci; 2006 Nov; 79(23):2179-86. PubMed ID: 16914164
[TBL] [Abstract][Full Text] [Related]
18. Differences in chlorzoxazone metabolism in full mature male and female Sprague-Dawley rat, Beagle dog and Cynomolgus monkey liver.
Tanaka E; Shimamoto A; Nakamura T; Terao K; Misawa S
Hum Exp Toxicol; 2000 Feb; 19(2):122-5. PubMed ID: 10773842
[No Abstract] [Full Text] [Related]
19. Chlorzoxazone metabolism is increased in fasted Sprague-Dawley rats.
Wan J; Ernstgård L; Song BJ; Shoaf SE
J Pharm Pharmacol; 2006 Jan; 58(1):51-61. PubMed ID: 16393464
[TBL] [Abstract][Full Text] [Related]
20. Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.
Ahn CY; Kim EJ; Lee I; Kwon JW; Kim WB; Kim SG; Lee MG
J Pharm Sci; 2003 Aug; 92(8):1604-13. PubMed ID: 12884247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
